Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Injectable healing protocol: Dose: 2-3mg daily (higher end of range) Frequency: Daily throughout healing period Duration: Until wound resolves plus 1-2 weeks Injection site: Systemic (not into wound) Topical healing protocol: Concentration: 2-4% in wound-appropriate vehicle Application: 2-3 times daily to wound margins (not directly into open wounds) Duration: Throughout healing process Note: Consult healthcare provider for significant wounds GHK-CU pairs exceptionally well with BPC-157 and TB-500 for wound healing
Extended-release formulations have slightly lower absorption but offer the advantage of a more stable drug concentration
References Compliance Notice This product is intended for laboratory research use only and is not approved for human or veterinary use.
When prescribed and monitored by a licensed medical provider, Dihexa has shown excellent tolerance with minimal side effects
Let's break down the key sections of a typical COA for BPC-157 provided by a reputable supplier
